How effective is Rowasa for Colitis Ulcerative (Ulcerative colitis) ?

Summary

Overall ratings: 3.5/5
Long term ratings: 3/5

This is a reivew of how effective Rowasa (mesalamine) is for Colitis ulcerative and for what kind of people. The study is created by eHealthMe from 6 Rowasa users and is updated continuously.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on mesalamine (the active ingredients of Rowasa) and Rowasa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Rowasa?

Rowasa has active ingredients of mesalamine. It is often used in ulcerative colitis. (latest outcomes from Rowasa 803 users)

What is Colitis ulcerative?

Colitis ulcerative (inflammation of colon with ulcer) has been reported by people with acne, ulcerative colitis, high blood pressure, rheumatoid arthritis, crohn's disease (latest reports from 67,858 Colitis ulcerative patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 21, 2019

6 people are studied for taking Rowasa in Colitis ulcerative


Overall effectiveness (number of people)

Does Rowasa work for your Colitis ulcerative (overall)?

Long term effectiveness (number of people)

Does Rowasa work for your Colitis ulcerative (long term)?

Rowasa effectiveness for Colitis ulcerative (number of people)

Overall:
  • not at all: 0
  • somewhat: 2
  • moderate: 0
  • high: 3
  • very high: 1
Long Term:
  • not at all: 0
  • somewhat: 2
  • moderate: 0
  • high: 2
  • very high: 0

Gender of people who take Rowasa for Colitis ulcerative *

  • female: 83.33 %
  • male: 16.67 %

Age of people who take Rowasa for Colitis ulcerative *

  • 0-1: 0.0 %
  • 2-9: 16.67 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 33.33 %
  • 40-49: 16.67 %
  • 50-59: 0.0 %
  • 60+: 33.33 %

Who finds Rowasa more effective for Colitis Ulcerative?


Gender of people who take Rowasa for Colitis ulcerative *

  • female: 75 %
  • male: 25 %

Age of people who take Rowasa for Colitis ulcerative *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 50 %
  • 40-49: 25 %
  • 50-59: 0.0 %
  • 60+: 25 %

* Approximation only. Some reports may have incomplete information.


Do you take Rowasa?

You are not alone:




Related studies:



Recent updates

Recent general studies
Recent personal studies


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.